Predictive analytics
The company scored Class III Shonin clearance in Japan for its stroke platform and launched Rapid Edge Cloud, allowing continued AI access despite cloud connectivity.
The medtech company announced 40 innovations at RSNA23 aimed at streamlining the provider and patient healthcare experience.
The funds will be used to develop a comprehensive AI imaging model powered by imaging data to improve diagnostic precisions and early detection of conditions.
The company showcased new informatics solutions at RSNA23 in Chicago, including a "helium-free" mobile MRI system and an AI-enabled advanced visualization workshop.
The healthcare technology company will evaluate the impact of the City of San Antonio's Racial and Ethnic Approaches to Community Health (REACH) project.
It can potentially help doctors prevent or better manage kidney disease in patients with Type 2 diabetes.
It has been approved for use in both clinical and home settings.
Also, Syntekabio has launched its cloud service platform for AI drug discovery.
It is part of an artificial pancreas system that mimics the human body's closed-loop system for insulin production.
The technology uses heart rate variability measurements to assess the severity of sepsis in ED patients.